KMT2A and acute lymphoblastic leukemia: Of note, the Archer® FusionPlex® ALL open-ended PCR approach can detect previously unknown fusion genes and any partner of promiscuous genes; this is especially relevant in the BCP-ALL setting, as it allows to detect clinically relevant fusions involving KMT2A gene, as well as heterogeneous rearrangements involved in the Ph-like subtype.